Results 191 to 200 of about 90,474 (293)
Limitations of PIV Biomarker Analysis Related to Chemoradiotherapy and Unadjusted Confounders
The pan‐immune‐inflammation value (PIV) derived from four blood cell counts warrants cautious interpretation in rectal‐cancer immunotherapy, as CRT cannot be disentangled from anti‐PD‐1 effects within the small n = 16 subgroup.
Hongbo Gao, Wencai Weng
wiley +1 more source
Distinct Humoral Response Development to Measles Virus Across Vaccine Platforms. [PDF]
Chan AKP +5 more
europepmc +1 more source
In 5829 Korean patients undergoing hereditary cancer germline testing, 987 (16.9%) carried pathogenic/likely pathogenic variants. Post‐test management varied substantially across gene groups, while variant reclassification identified 46 additional carriers, underscoring the need for gene‐specific management and structured recontact.
Min‐Chae Kang +13 more
wiley +1 more source
Endometrial Giant Cell Carcinoma Integrating Morphology, Immunophenotype, and Molecular Findings in a Misdiagnosed Case. [PDF]
Alfaqih OY, Mehecy SB, Elhassan MAM.
europepmc +1 more source
Schematic of the clinical algorithm for diagnosing hereditary cancer syndromes using MGPT. ABSTRACT In March 2025, the Japanese Society for Hereditary Tumors and the Ministry of Health, Labour and Welfare (MHLW) Research on Promotion of Cancer Control Program Grant Number JPMH 23EA1037 published the “Japanese Society for Hereditary Tumors Guidance ...
Reiko Yoshida +66 more
wiley +1 more source
Replication Stress Tolerance in Adult T-Cell Leukemia. [PDF]
Okamoto Y +4 more
europepmc +1 more source
From Control to Elimination: Making the End of Dental Caries Thinkable
ABSTRACT Background Dental caries remains one of the most prevalent noncommunicable diseases worldwide despite decades of clinical and behavioural interventions. Persistently high prevalence suggests that current approaches are better organised for ongoing disease management than for preventing new disease occurrence.
Habib Benzian +2 more
wiley +1 more source

